STL Volume 15 Number 9
3 POSTS 0 COMMENTSPurchase PDF for $2.79
Update on Drugs and Drug News: October 2010
October 2010: Update on drugs, approval dates, and comments. Velaglucerase alfa (VPRIV®), and recent news with Health Canada.
Nanodermatology: A Glimpse of Caution Just Beyond the Horizon – Part II
Nanotechnology applies the unique properties of matter on the nanoscale (1000 nm and smaller) for the purposeful design of new materials. Dermatology is already one of the leading beneficiaries of nanotechnology.
The Current Management of Delusional Parasitosis and Dermatitis Artefacta
Psychocutaneous disorders involve a unique and somewhat difficult patient population. This paper describes an effective interpersonal approach and appropriate drug therapy for patients with delusional disorders and dermatitis artefacta.